You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EGFR C797s

Showing 1 - 25 of 3,160
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

Recruiting
  • Lung Neoplasms
  • +23 more
  • La Jolla, California
  • +35 more
Oct 6, 2022

Advanced or Metastatic NSCLC Trial in Guangzhou (HS-10375)

Recruiting
  • Advanced or Metastatic NSCLC
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 27, 2022

NSCLC Trial (TAS3351 oral administration)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • TAS3351 oral administration
  • (no location specified)
Mar 8, 2023

EGFR Mutant Advanced NSCLC Trial (BBT-207)

Not yet recruiting
  • EGFR Mutant Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Jun 16, 2023

NSCLC Trial (QLH11811)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Sep 22, 2022

Non-small Cell Lung Carcinoma Trial (BPI-361175)

Not yet recruiting
  • Non-small Cell Lung Carcinoma
  • (no location specified)
Oct 18, 2022

Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III

Terminated
  • Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +9 more
  • Bintrafusp Alfa
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 4, 2022

Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations Trial in Worldwide (Neratinib, Fulvestrant, Trastuzumab)

Active, not recruiting
  • Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
  • Birmingham, Alabama
  • +59 more
Mar 3, 2022

Lung Adenocarcinoma, Lung Tumors Trial run by the NCI (osimertinib, LAT)

Completed
  • Lung Adenocarcinoma
  • Lung Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 17, 2022

Non-Small-Cell Lung Cancer Trial in Worldwide (Amivantamab, Lazertinib, Carboplatin)

Recruiting
  • Non-Small-Cell Lung Cancer
  • Duarte, California
  • +100 more
Jan 31, 2023

EGFR Gene Mutation, Lung Cancer, Lung Cancer Metastatic Trial in United States (Dacomitinib, Osimertinib)

Recruiting
  • EGFR Gene Mutation
  • +2 more
  • Basking Ridge, New Jersey
  • +7 more
Aug 27, 2021

NSCLC, EGFR Gene Mutation, EGF-R Positive NSCLC Trial in Jerusalem (Stereotactic surgery)

Recruiting
  • NSCLC
  • +4 more
  • Stereotactic surgery
  • Jerusalem, Israel
    Hadassah Ein Kerem Medical Center
Aug 30, 2021

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive)

Recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +4 more
  • Cetuximab
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 4, 2021

EGFR Mutant Advanced NSCLC Trial (JIN-A02)

Not yet recruiting
  • EGFR Mutant Advanced Non-small Cell Lung Cancer
  • (no location specified)
Jul 8, 2022

NSCLC Trial (Furmonertinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Aug 10, 2023

Lung Cancer Trial in Worldwide (T790M+ Testing, Baseline Visit Blood & Urine Testing, Baseline ECG)

Completed
Has Results
  • Lung Cancer
  • T790M+ Testing
  • +4 more
  • Buenos Aires, Argentina
  • +200 more
Nov 10, 2021

NSCLC Trial in Singapore (Afatinib 40 MG)

Not yet recruiting
  • NSCLC
  • Afatinib 40 MG
  • Singapore, Singapore
    National University Hospital
Sep 25, 2023

Metastatic NSCLC Trial in Worldwide (Ramucirumab, Placebo, Erlotinib)

Active, not recruiting
Has Results
  • Metastatic Non-Small Cell Lung Cancer
  • Los Angeles, California
  • +109 more
Apr 18, 2022

Non-small-cell Lung Carcinoma Trial in Netherlands (biopsy, ctDAN analysis)

Recruiting
  • Non-small-cell Lung Carcinoma
  • biopsy
  • ctDAN analysis
  • Amsterdam, Noord-Holland, Netherlands
  • +5 more
Feb 2, 2021

Lung Cancer, TKI Resistance, EGFR Sensitive Mutation Trial (Anlotinib, Penpulimab)

Not yet recruiting
  • Lung Cancer
  • +4 more
  • (no location specified)
Sep 15, 2023

Frontline Afatinib Followed by 2nd Line Therapy Including

Active, not recruiting
  • NSCLC
  • Seoul, Korea, Republic of
    Jin Hyoung Kang
Jun 13, 2021

Non Small Cell Lung Cancer Trial in Seoul (Neoadjuvant lazertinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Neoadjuvant lazertinib
  • Seoul, Korea, Republic of
    Konkuk University Medical Center
Jul 20, 2022

Non-squamous NSCLC Trial in Guangzhou (FSRT combined with Bevacizumab)

Active, not recruiting
  • Non-squamous Non-small Cell Lung Cancer
  • FSRT combined with Bevacizumab
  • Guangzhou, China
    Sun Yat-sen University
Nov 25, 2022

Chronic Kidney Disease Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

Recruiting
  • Chronic Kidney Disease
  • Huntsville, Alabama
  • +251 more
Dec 22, 2022